Eligibility Module
The Eligibility Module contains detailed information about who can participate in the clinical trial. This includes eligibility criteria, age restrictions, gender requirements, healthy volunteer status, and study population descriptions, helping researchers understand who is eligible to participate in the study.
Eligibility Module path is as follows:
Study -> Protocol Section -> Eligibility Module
Eligibility Module
Ignite Creation Date:
2025-12-24 @ 11:40 PM
Ignite Modification Date:
2025-12-24 @ 11:40 PM
NCT ID:
NCT00430651
Eligibility Criteria:
Inclusion Criteria:
* Histologically or cytologically confirmed NSCLC.
* ECOG Performance Status 0-2.
* No previous treatment with Docetaxel.
* Measurable Disease.
* Brain metastases that have been treated with radiotherapy should be stable and asymptomatic.
* Adequate liver kidney and bone marrow function.
* Patients must be able to understand the nature of this study and give written informed consent.
Exclusion Criteria:
* Active cardiac disease: unstable angina or onset of angina within last 3 months, myocardial infarction within 6 months, congestive heart failure \> class II, cardiac ventricular arrhythmias requiring anti-arrhythmic therapy.
* Women who are pregnant or lactating.
* Unknown HIV, chronic hepatitis B or chronic hepatitis C infections.
* Serious neurologic or psychiatric disease.
* Second primary malignancy within the past 5 years, except nonmelanomas skin cancer or in situ carcinoma of the cervix.
* Active uncontrolled infection.
Healthy Volunteers:
False
Sex:
ALL
Minimum Age:
18 Years
Maximum Age:
75 Years
Study:
NCT00430651
Study Brief:
Protocol Section:
NCT00430651